{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:05:25Z","timestamp":1789517125202,"version":"build-2803163510"},"reference-count":76,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["NIH R01-CA-281976"],"award-info":[{"award-number":["NIH R01-CA-281976"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["NIH R34-CA-286602"],"award-info":[{"award-number":["NIH R34-CA-286602"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH R03-CA-283105"],"award-info":[{"award-number":["NIH R03-CA-283105"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH R37-CA-294177"],"award-info":[{"award-number":["NIH R37-CA-294177"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The 2025 American Thyroid Association (ATA) Management Guidelines for Adult Patients with Differentiated Thyroid Cancer focus on the care of patients with low- to high-risk disease with management recommendations reflecting the evolving evidence in the field. Most patients diagnosed with differentiated thyroid cancer have low-risk disease. For the care of patients with low-risk disease, the new clinical guidelines emphasize shared decision-making, de-escalating care in patients who are recurrence free, and long-term survivorship care. We present 3 cases of patients with diagnoses of low-risk differentiated thyroid cancer to illustrate management options and key considerations.<\/jats:p>","DOI":"10.1210\/clinem\/dgag243","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:31:36Z","timestamp":1782289896000},"page":"2960-2968","source":"Crossref","is-referenced-by-count":0,"title":["Approach to the patient with low-risk thyroid cancer"],"prefix":"10.1210","volume":"111","author":[{"given":"Susan C","family":"Pitt","sequence":"first","affiliation":[{"name":"Division of Endocrine Surgery, Department of Surgery, University of Michigan , Ann Arbor, MI 48109 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1083-1575","authenticated-orcid":false,"given":"Megan R","family":"Haymart","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology & Diabetes, University of Michigan , Ann Arbor, MI 48109 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"2026091519590271800_dgag243-B1","author":"NIH; National Cancer Institute. Surveillance, Epidemiology, and End Results Program"},{"key":"2026091519590271800_dgag243-B2","author":"American Cancer Society"},{"issue":"3","key":"2026091519590271800_dgag243-B3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jnci\/djae250","article-title":"Prevalence of cancer survivors diagnosed during adolescence and young adulthood in the United States","volume":"117","author":"Page","year":"2025","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"2026091519590271800_dgag243-B4","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1210\/jc.2014-2197","article-title":"Tree-based model for thyroid cancer prognostication","volume":"99","author":"Banerjee","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026091519590271800_dgag243-B5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1210\/jc.2018-01933","article-title":"Thyroid ultrasound and the increase in diagnosis of low-risk thyroid cancer","volume":"104","author":"Haymart","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"10387","key":"2026091519590271800_dgag243-B6","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","article-title":"Thyroid cancer","volume":"401","author":"Chen","year":"2023","journal-title":"Lancet"},{"issue":"8","key":"2026091519590271800_dgag243-B7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"issue":"10","key":"2026091519590271800_dgag243-B8","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1470-2045(25)00424-3","article-title":"Tumour genetics and thyroid cancer staging: a balancing act","volume":"26","author":"Pitt","year":"2025","journal-title":"Lancet Oncol"},{"issue":"10","key":"2026091519590271800_dgag243-B9","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S1470-2045(25)00399-7","article-title":"Genetic modification of the AJCC classification of papillary thyroid cancer: an international, multicentre, retrospective cohort study","volume":"26","author":"Xing","year":"2025","journal-title":"Lancet Oncol"},{"key":"2026091519590271800_dgag243-B10","volume-title":"AJCC Cancer Staging Manual","author":"Edge","year":"2017","edition":"8th ed"},{"issue":"5","key":"2026091519590271800_dgag243-B11","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/jamaoto.2023.0101","article-title":"Challenges of shared decision-making by clinicians and patients with low-risk differentiated thyroid cancer: a systematic review and meta-ethnography","volume":"149","author":"Yang","year":"2023","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2026091519590271800_dgag243-B12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejca.2022.11.005","article-title":"Position paper from the Endocrine Task Force of the European Organisation for Research and Treatment of Cancer (EORTC) on the management and shared decision making in patients with low-risk micro papillary thyroid carcinoma","volume":"179","author":"Koot","year":"2023","journal-title":"Eur J Cancer"},{"issue":"4","key":"2026091519590271800_dgag243-B13","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.suc.2024.02.003","article-title":"Management of small papillary thyroid cancers","volume":"104","author":"Fields","year":"2024","journal-title":"Surg Clin North Am"},{"issue":"8","key":"2026091519590271800_dgag243-B14","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.eprac.2025.04.016","article-title":"Harnessing the power of physician word choice in thyroid cancer treatment decision-making","volume":"31","author":"Jensen","year":"2025","journal-title":"Endocr Pract"},{"issue":"2","key":"2026091519590271800_dgag243-B15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/SLA.0000000000006347","article-title":"Making choices: a multi-institutional, longitudinal cohort study assessing changes in treatment outcome valuation for low-risk thyroid cancer","volume":"282","author":"Antunez","year":"2025","journal-title":"Ann Surg"},{"issue":"9","key":"2026091519590271800_dgag243-B16","first-page":"1039","article-title":"The 2023 Bethesda system for reporting thyroid cytopathology","volume":"33","author":"Ali","year":"2023","journal-title":"Thyroid"},{"issue":"2","key":"2026091519590271800_dgag243-B17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1089\/thy.2015.0376","article-title":"Bethesda categorization of thyroid nodule cytology and prediction of thyroid cancer type and prognosis","volume":"26","author":"Liu","year":"2016","journal-title":"Thyroid"},{"issue":"1","key":"2026091519590271800_dgag243-B18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/cen.70032","article-title":"Guiding management of Bethesda V thyroid nodules: the role of molecular testing","volume":"104","author":"Tessler","year":"2026","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2026091519590271800_dgag243-B19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaoto.2023.1494","article-title":"Prognostic value of preoperative molecular testing and implications for initial surgical management in thyroid nodules harboring suspected (Bethesda V) or known (Bethesda VI) papillary thyroid cancer","volume":"149","author":"Schumm","year":"2023","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"7","key":"2026091519590271800_dgag243-B20","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.3390\/jcm9072316","article-title":"The impact of the extent of surgery on the long-term outcomes of patients with low-risk differentiated non-medullary thyroid cancer: a systematic meta-analysis","volume":"9","author":"Bojoga","year":"2020","journal-title":"J Clin Med"},{"issue":"9","key":"2026091519590271800_dgag243-B21","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1245\/s10434-018-6550-2","article-title":"Impact of extent of surgery on tumor recurrence and survival for papillary thyroid cancer patients","volume":"25","author":"Gartland","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"2026091519590271800_dgag243-B22","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/bjs5.50359","article-title":"Hemithyroidectomy versus total thyroidectomy for well differentiated T1-2 N0 thyroid cancer: systematic review and meta-analysis","volume":"4","author":"Rodriguez Schaap","year":"2020","journal-title":"BJS Open"},{"issue":"1","key":"2026091519590271800_dgag243-B23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00268-009-0303-0","article-title":"An observational trial for papillary thyroid microcarcinoma in Japanese patients","volume":"34","author":"Ito","year":"2010","journal-title":"World J Surg"},{"issue":"1","key":"2026091519590271800_dgag243-B24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/thy.2013.0367","article-title":"Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation","volume":"24","author":"Ito","year":"2014","journal-title":"Thyroid"},{"issue":"10","key":"2026091519590271800_dgag243-B25","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jamaoto.2017.1442","article-title":"Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance","volume":"143","author":"Tuttle","year":"2017","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"11","key":"2026091519590271800_dgag243-B26","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1001\/jamaoncol.2022.3875","article-title":"Expanded parameters in active surveillance for low-risk papillary thyroid carcinoma: a nonrandomized controlled trial","volume":"8","author":"Ho","year":"2022","journal-title":"JAMA Oncol"},{"issue":"7","key":"2026091519590271800_dgag243-B27","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1089\/thy.2019.0592","article-title":"A prospective mixed-methods study of decision-making on surgery or active surveillance for low-risk papillary thyroid cancer","volume":"30","author":"Sawka","year":"2020","journal-title":"Thyroid"},{"key":"2026091519590271800_dgag243-B28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jss.2019.04.036","article-title":"Lobectomy compared to total thyroidectomy for low-risk papillary thyroid cancer: a systematic review","volume":"242","author":"Vargas-Pinto","year":"2019","journal-title":"J Surg Res"},{"issue":"6","key":"2026091519590271800_dgag243-B29","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019073","article-title":"Total thyroidectomy versus lobectomy for papillary thyroid cancer: a systematic review and meta-analysis","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"2026091519590271800_dgag243-B30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJMoa2111953","article-title":"Thyroidectomy without radioiodine in patients with low-risk thyroid cancer","volume":"386","author":"Leboulleux","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"2026091519590271800_dgag243-B31","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2011-2512","article-title":"Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients","volume":"97","author":"Schvartz","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026091519590271800_dgag243-B32","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1089\/thy.2010.0308","article-title":"Radioiodine therapy in patients with stage I differentiated thyroid cancer","volume":"20","author":"Jonklaas","year":"2010","journal-title":"Thyroid"},{"issue":"1","key":"2026091519590271800_dgag243-B33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.surg.2017.04.039","article-title":"Lobectomy for treatment of differentiated thyroid cancer: can patients avoid postoperative thyroid hormone supplementation and be compliant with the American Thyroid Association guidelines?","volume":"163","author":"Cox","year":"2018","journal-title":"Surgery"},{"issue":"10","key":"2026091519590271800_dgag243-B34","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1001\/archotol.134.10.1076","article-title":"Thyroid function after unilateral total lobectomy: risk factors for postoperative hypothyroidism","volume":"134","author":"De Carlucci","year":"2008","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"1","key":"2026091519590271800_dgag243-B35","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1038\/s41598-020-62731-3","article-title":"Health-related quality of life analysis in differentiated thyroid carcinoma patients after thyroidectomy","volume":"10","author":"Li","year":"2020","journal-title":"Sci Rep"},{"issue":"7","key":"2026091519590271800_dgag243-B36","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.eprac.2021.01.004","article-title":"Frequency of thyroid hormone replacement after lobectomy for differentiated thyroid cancer","volume":"27","author":"Schumm","year":"2021","journal-title":"Endocr Pract"},{"issue":"2","key":"2026091519590271800_dgag243-B37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jc.2017-01616","article-title":"Natural history of contralateral nodules after lobectomy in patients with papillary thyroid carcinoma","volume":"103","author":"Ritter","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026091519590271800_dgag243-B38","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/thy.2012.0269","article-title":"Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin","volume":"23","author":"Nilubol","year":"2013","journal-title":"Thyroid"},{"issue":"1","key":"2026091519590271800_dgag243-B39","article-title":"Male sex is not an independent risk factor for recurrence of differentiated thyroid cancer: a propensity score-matching study","volume":"11","author":"Park","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"2026091519590271800_dgag243-B40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.surg.2022.05.049","article-title":"What do patients want to know about surgery for low-risk thyroid cancer? A qualitative study","volume":"173","author":"Underwood","year":"2023","journal-title":"Surgery"},{"key":"2026091519590271800_dgag243-B41","author":"NIH; National Cancer Institute"},{"issue":"11","key":"2026091519590271800_dgag243-B42","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/jnci\/djz089","article-title":"Developing a quality of cancer survivorship care framework: implications for clinical care, research, and policy","volume":"111","author":"Nekhlyudov","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"2026091519590271800_dgag243-B43","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1210\/JC.2015-1346","article-title":"Long-term outcomes following therapy in differentiated thyroid carcinoma: NTCTCS registry analysis 1987-2012","volume":"100","author":"Carhill","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026091519590271800_dgag243-B44","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1089\/thy.2023.0711","article-title":"The effect of thyrotropin suppression on survival outcomes in patients with differentiated thyroid cancer: a systematic review and meta-analysis","volume":"34","author":"Gubbi","year":"2024","journal-title":"Thyroid"},{"issue":"2","key":"2026091519590271800_dgag243-B45","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/thy.2024.0330","article-title":"Association between serum thyrotropin and cancer recurrence in differentiated thyroid cancer: a population-based retrospective cohort study","volume":"35","author":"Qiang","year":"2025","journal-title":"Thyroid"},{"issue":"6","key":"2026091519590271800_dgag243-B46","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/thy.2021.0666","article-title":"Serum thyroglobulin measurement following surgery without radioactive iodine for differentiated thyroid cancer: a systematic review","volume":"32","author":"Chou","year":"2022","journal-title":"Thyroid"},{"issue":"1","key":"2026091519590271800_dgag243-B47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/10507256251409134","article-title":"Thyroglobulin cutoffs after total thyroidectomy without radioiodine in low- to intermediate-risk thyroid cancer: a multicenter cohort study","volume":"36","author":"Kim","year":"2026","journal-title":"Thyroid"},{"issue":"23","key":"2026091519590271800_dgag243-B48","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1002\/cncr.29633","article-title":"Cost-effectiveness analysis of papillary thyroid cancer surveillance","volume":"121","author":"Wang","year":"2015","journal-title":"Cancer"},{"key":"2026091519590271800_dgag243-B49","article-title":"Use of imaging tests after primary treatment of thyroid cancer in the United States: population based retrospective cohort study evaluating death and recurrence","volume":"354","author":"Banerjee","year":"2016","journal-title":"BMJ"},{"issue":"12","key":"2026091519590271800_dgag243-B50","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.4158\/EP15851.OR","article-title":"Serial neck ultrasound is more likely to identify false-positive abnormalities than clinically significant disease in low-risk papillary thyroid cancer patients","volume":"21","author":"Yang","year":"2015","journal-title":"Endocr Pract"},{"issue":"8","key":"2026091519590271800_dgag243-B51","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.eprac.2025.04.020","article-title":"Use of neck ultrasound as surveillance in older adults with thyroid cancer","volume":"31","author":"Francis-Levin","year":"2025","journal-title":"Endocr Pract"},{"key":"2026091519590271800_dgag243-B52","author":"NIH; National Cancer Institute"},{"issue":"12","key":"2026091519590271800_dgag243-B53","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1245\/s10434-014-3846-8","article-title":"Total thyroidectomy is associated with increased risk of complications for low- and high-volume surgeons","volume":"21","author":"Hauch","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"2026091519590271800_dgag243-B54","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1210\/jc.2017-00255","article-title":"Population-based assessment of complications following surgery for thyroid cancer","volume":"102","author":"Papaleontiou","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026091519590271800_dgag243-B55","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1089\/thy.2017.0309","article-title":"American Thyroid Association statement on postoperative hypoparathyroidism: diagnosis, prevention, and management in adults","volume":"28","author":"Orloff","year":"2018","journal-title":"Thyroid"},{"issue":"5","key":"2026091519590271800_dgag243-B56","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.suc.2021.05.019","article-title":"Endocrine surgery: management of postoperative complications following endocrine surgery of the neck","volume":"101","author":"Fackelmayer","year":"2021","journal-title":"Surg Clin North Am"},{"issue":"12","key":"2026091519590271800_dgag243-B57","doi-asserted-by":"crossref","first-page":"e4652","DOI":"10.1210\/clinem\/dgaa597","article-title":"Quality of life in patients with hypoparathyroidism after treatment for thyroid cancer","volume":"105","author":"Buttner","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026091519590271800_dgag243-B58","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jamaoto.2019.1737","article-title":"Assessment of voice outcomes following surgery for thyroid cancer","volume":"145","author":"Kovatch","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"6","key":"2026091519590271800_dgag243-B59","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.surg.2021.04.060","article-title":"Long-term voice changes after thyroidectomy: results from a validated survey","volume":"170","author":"Li","year":"2021","journal-title":"Surgery"},{"issue":"6","key":"2026091519590271800_dgag243-B60","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/00000658-200212000-00015","article-title":"Prospective functional voice assessment in patients undergoing thyroid surgery","volume":"236","author":"Stojadinovic","year":"2002","journal-title":"Ann Surg"},{"issue":"Suppl 6","key":"2026091519590271800_dgag243-B61","first-page":"S1","article-title":"Clinical practice guideline: improving voice outcomes after thyroid surgery","volume":"148","author":"Chandrasekhar","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"9","key":"2026091519590271800_dgag243-B62","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/00005537-200409000-00009","article-title":"Development and validation of the voice handicap index-10","volume":"114","author":"Rosen","year":"2004","journal-title":"Laryngoscope"},{"issue":"1","key":"2026091519590271800_dgag243-B63","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.surg.2019.04.068","article-title":"Energy level and fatigue after surgery for thyroid cancer: a population-based study of patient-reported outcomes","volume":"167","author":"Hughes","year":"2020","journal-title":"Surgery"},{"issue":"2","key":"2026091519590271800_dgag243-B64","doi-asserted-by":"crossref","DOI":"10.1530\/EC-21-0506","article-title":"Fatigue and quality of life among thyroid cancer survivors without persistent or recurrent disease","volume":"11","author":"Maki","year":"2022","journal-title":"Endocr Connect"},{"issue":"8","key":"2026091519590271800_dgag243-B65","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1089\/thy.2019.0163","article-title":"Worry in thyroid cancer survivors with a favorable prognosis","volume":"29","author":"Papaleontiou","year":"2019","journal-title":"Thyroid"},{"issue":"4","key":"2026091519590271800_dgag243-B66","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s11764-021-01078-8","article-title":"Change in worry over time among hispanic women with thyroid cancer","volume":"16","author":"Levin","year":"2022","journal-title":"J Cancer Surviv"},{"issue":"5","key":"2026091519590271800_dgag243-B67","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/MED.0000000000000815","article-title":"The psychosocial impact of thyroid cancer","volume":"30","author":"Haymart","year":"2023","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"9","key":"2026091519590271800_dgag243-B68","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1245\/s10434-025-17586-1","article-title":"Thyroid cancer-specific worry in the United States: a survey","volume":"32","author":"Evans","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"2026091519590271800_dgag243-B69","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1210\/clinem\/dgae688","article-title":"Cancer-related fear and worry in patients with low-risk thyroid cancer: a longitudinal cohort study","volume":"110","author":"Lee","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026091519590271800_dgag243-B70","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/cncr.32670","article-title":"Disparities in risk perception of thyroid cancer recurrence and death","volume":"126","author":"Chen","year":"2020","journal-title":"Cancer"},{"issue":"3","key":"2026091519590271800_dgag243-B71","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00268-015-3300-5","article-title":"Quality of life in thyroid cancer is similar to that of other cancers with worse survival","volume":"40","author":"Applewhite","year":"2016","journal-title":"World J Surg"},{"issue":"3","key":"2026091519590271800_dgag243-B72","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s11764-020-00937-0","article-title":"Physician management of thyroid cancer patients' worry","volume":"15","author":"Papaleontiou","year":"2021","journal-title":"J Cancer Surviv"},{"issue":"7","key":"2026091519590271800_dgag243-B73","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1089\/thy.2016.0632","article-title":"Papillary thyroid cancer: the good and bad of the \u201cgood cancer\u201d","volume":"27","author":"Randle","year":"2017","journal-title":"Thyroid"},{"issue":"6","key":"2026091519590271800_dgag243-B74","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/thy.2015.0032","article-title":"Support needs and survivorship concerns of thyroid cancer patients","volume":"25","author":"Morley","year":"2015","journal-title":"Thyroid"},{"key":"2026091519590271800_dgag243-B75","author":"ThyCa: Thyroid Cancer Survivors' Association, Inc"},{"key":"2026091519590271800_dgag243-B76","author":"NCCN"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag243\/68601661\/dgag243.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/10\/2960\/68601661\/dgag243.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/10\/2960\/68601661\/dgag243.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:59:17Z","timestamp":1789516757000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/10\/2960\/8715176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":76,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,6,24]]},"published-print":{"date-parts":[[2026,9,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag243","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,6,24]]}}}